Role of Macrophages and Interferon in Natural Resistance to Mouse Hepatitis Virus Infection

  • Jean-Louis Virelizier
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 92)

Abstract

Among the many models of experimental viral infections, the mouse hepatitis virus (MHV) model offers a number of advantages for investigation of the host-virus relationship:
  1. 1.

    MHV infection is a naturally occurring infection in the mouse (Rowe et al. 1963); Broderson et al. 1976; Ishida et al. 1978) and thus is not an artificial model.

     
  2. 2.

    In the case of mouse hepatitis virus type 3 (MHV-3), the natural resistance is observed to various degrees according to the mouse strain considered (Virelizier and Allison 1976), with either full susceptibility, full resistance, or semiresistance being present This provides the opportunity to make correlations with parameters of the immune response in a more precise manner than in other models where only two situations (susceptibility and resistance) are observed.

     
  3. 3.

    The mouse strains showing variable degrees of susceptibility to MHV-3 (namely, A/J, C3H/He, and C57/BL-6) are well-known inbred strains whose biologic parameters have been thoroughly investigated.

     
  4. 4.

    MHV infections have been among the first models in which the role of macrophages in host defense have been investigated after the pioneering studies of F. Bang and his colleagues (Bang and Warwick 1960; Shif and Bang 1970).

     
  5. 5.

    MHV-3 induces a very easily recognizable cytopathic effect in mouse macrophage cultures by fusing infected macrophages into multinucleated giant cells (Malucci 1965). The appearance of this cytopathic effect closely parallels the intensity of viral replication and thus provides a useful tool for in vitro studies in macrophages from different strains of mice (Virelizier and Allison 1976).

     
  6. 6.

    MHV-3 infection is so far the only Coronavirus model in which the protective role of interferon in vivo has been demonstrated (Virelizier and Gresser 1978).

     
  7. 7.

    Finally, the modification of immune responsiveness during acute or persistent infections has been investigated (Virelizier et al. 1976).

     

Keywords

Hepatitis Influenza Sarcoma Diarrhea Interferon 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allison AC (1965) Genetic factors in resistance against virus infections. Arch Gesamte Virusforsch 17:280–293PubMedCrossRefGoogle Scholar
  2. Allison AC (1978) Role of macrophages in the immune response. Immunol Rev 40:3PubMedCrossRefGoogle Scholar
  3. Allison AC, Harington JS, Birbeck M (1966) An examination of the cytotoxic effects of silica on macrophages. J Exp Med 124:141–153PubMedCrossRefGoogle Scholar
  4. Arnheiter H, Haller O (to be published) Inborn resistance of mice to mouse hepatitis virus type 3 (MHV-3): liver parenchymal cell express phenotype in culture. In: Biochemistry and biology of coronavirusesGoogle Scholar
  5. Bang FB, Warwick A (1960) Mouse macrophages as host cells for the mouse hepatitis virus and the genetic basis of their susceptibility. Proc Natl Acad Sci USA 46:1065–1075PubMedCrossRefGoogle Scholar
  6. Baron S (1973) The defensive and biological roles of the interferon system. Front Biol 2:267–280Google Scholar
  7. Boraschi D, Meltzer MS (1979) Defective tumoricidal capacity of macrophages from A/J mice. II: Comparison of the macrophage cytotoxic defect of A/J mice with of lipid A-unresponsive C3H/HeJ mice. J Immunol 122:1592–1597PubMedGoogle Scholar
  8. Broderson JR, Murphy FA, Hierholzer JC (1976) Lethal enteritis in infant mice caused by mouse hepatitis virus. Lab Anim Sci 26:824–827PubMedGoogle Scholar
  9. Cowing C, Pincus SH, Sachs DH, Dickler HB (1978) A subpopulation of adherent accessory cells bearing both I-A and I-E or C subregion antigens is required for antigen specific murine T lymphocyte proliferation. J Immunol 121:1680–1685PubMedGoogle Scholar
  10. De Maeyer E, Jullien P, De Maeyer-Guignard J, Demant P (1975) Effect of mouse genotype on interferon production. II: Distribution of If-1 alleles among inbred strains and transfer of phenotype by grafting bone marrow cells. Immunogenetics 2:151–160CrossRefGoogle Scholar
  11. Dick GWA, Niven JSF, Gledhill AW (1956) A virus related to that causing hepatitis in mice. Br J Exp Pathol 37:90–95PubMedGoogle Scholar
  12. Dupuy JM, Levy-Leblond E, Le Prevost C (1975) Immunopathology of mouse hepatitis virus type 3 infection. II. Effect of immunosuppression in resistant mice. J Immunol 114:226–230PubMedGoogle Scholar
  13. Epstein LB, Stevens DA, Merigan TC (1972) Selective increase in lymphocyte interferon response to vaccinia antigen after revaccination. J Clin Invest 50:744–753CrossRefGoogle Scholar
  14. Epstein LB, Lee SHS, Epstein CJ (1980) Enhanced sensitivity of trisomy 21 monocytes to the maturation-inhibiting effect of interferon. Cell Immunol 50:191–194PubMedCrossRefGoogle Scholar
  15. Fauconnier B (1970) Augmentation de la pathogénicité virale par l’emploi de sérum anti-interféron in vivo. CR Acad Sci [D] (Paris) 271:1466–1470Google Scholar
  16. Finter NB (1973) Interferons and inducers in vivo. I. Antiviral effects in experimental animals. Front Biol 2:135–150Google Scholar
  17. Gallily R, Warwick A, Bang FB (1964) Effect of cortisone on genetic resistance to mouse hepatitis virus in vivo and in vitro. Proc Natl Acad Sci USA 51:1158–1164PubMedCrossRefGoogle Scholar
  18. Gidlund M, Orn A, Wigzell H, Senik A, Gresser I (1978) Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature 273:759–761PubMedCrossRefGoogle Scholar
  19. Glasgow LA, Habel K (1963) Interferon production by mouse leucocytes in vitro and in vivo. J Exp Med 117:149–155PubMedCrossRefGoogle Scholar
  20. Gresser I, Tovey MG, Bandu MT, Maury C, Brouty-Boye D (1976a) Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection. J Exp Med 144:1305–1315PubMedCrossRefGoogle Scholar
  21. Gresser I, Tovey MG, Maury C, Bandu MT (1976b) Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with Herpes simplex, Moloney sarcoma, Vesicular stomatitis, Newcastle disease and influenza viruses. J Exp Med 114:1316–1323CrossRefGoogle Scholar
  22. Haller O, Arnheiter H, Gresser I, Lindenmann J (1979) Genetically determined, interferon-dependent resistance to influenza virus in mice. J Exp Med 149:601–612PubMedCrossRefGoogle Scholar
  23. Hirsch MS, Zisman B, Allison AC (1970) Macrophages and age dependent resistance to herpes simplex virus in mice. J Immunol 104:1160–1165PubMedGoogle Scholar
  24. Ishida T, Taguchi F, Lee Y, Yamada A, Tamura T, Fujiwara K (1978) Isolation of mouse hepatitis virus from infant mice with fatal diarrhea. Lab Anim Sci 28:269–276PubMedGoogle Scholar
  25. Kantoch M, Warwick A, Bang FB (1963) Cellular nature of genetic susceptibility to a virus. J Exp Med 117:781–797PubMedCrossRefGoogle Scholar
  26. Lampert PW, Sims JK, Kniazeff A J (1973) Mechanism of demyelination in JHM virus encephalomyelitis. Electron microscopic studies. Acta Neuropathol (Berl) 24:76–85CrossRefGoogle Scholar
  27. Le Prevost C, Levy-Leblond E, Virelizier JL, Dupuy JM (1975a) Immunopathology of mouse hepatitis virus type 3 infection. I. Role of humoral and cellmediated immunity in resistance mechanisms. J Immunol 114:221–225PubMedGoogle Scholar
  28. Le Prevost C, Virelizier JL, Dupuy JM (1975b) Immunopathology of mouse hepatitis virus type 3 infection. III. Clinical and virologic observation of a persistent viral infection. J Immunol 115: 640–645PubMedGoogle Scholar
  29. Levy-Leblond E, Dupuy JM (1977) Neonatal susceptibility to MHV-3 infection in mice. I. Transfer off resistance. J Immunol 118:1219–1222PubMedGoogle Scholar
  30. Levy-Leblond E, Oth D, Dupuy JM (1979) Genetic study of mouse sensitivity to MHV-3 infection: influence of the H2 complex. J Immunol 122:1359–1362PubMedGoogle Scholar
  31. Lindahl P, Leary P, Gresser I (1972) Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes. Proc Natl Acad Sci USA 69:721–725PubMedCrossRefGoogle Scholar
  32. Lohmann-Mattes ML, Domizig W, Roder J (1979) Promonocytes have the functional characteristics of natural killer cells. J Immunol 123:1883–1887Google Scholar
  33. McFarland HF, Griffin DE, Johnson RT (1972) Specificity of the inflammatory response in viral encephalitis. I. Adoptive immunization of immunosuppressed mice with Sindbis virus. J Exp Med 136:216–220PubMedCrossRefGoogle Scholar
  34. McIntosh K (1974) Coronaviruses: a comparative review. Curr Top Microbiol Immunol 63:85–129Google Scholar
  35. Malucci L (1965) Observations on the growth of mouse hepatitis virus (MHV-3) in mouse macrophages. Virology 25:30–37CrossRefGoogle Scholar
  36. Mims CA (1964) Aspects of the pathogenesis of virus disease. Bacteriol Rev 28:30–71PubMedGoogle Scholar
  37. Miyai K, Slusser RJ, Ruebner BH (1963) Viral hepatitis in mice: an electron microscopic study. Exp Mol Pathol 2:464–480CrossRefGoogle Scholar
  38. Petranyi GG, Kiessling R, Klein G (1975) Genetic control of natural killer lymphocytes in the mouse. Immunogenetics 2:53–61CrossRefGoogle Scholar
  39. Piazza M, Pane G, De Ritis F (1977) The fate of MHV-3 after intravenous injection into susceptible mice. Arch Gesamte Virusforsch 22:472–474CrossRefGoogle Scholar
  40. Roda SJ, White DO (1976) Cytotoxic macrophages: a rapid nonspecific response to viral infection. J Immunol 117:2067–2072Google Scholar
  41. Rowe WP, Hartley JW, Capps WI (1963) Mouse hepatitis virus infection as a highly contagious, prevalent, enteric infection in mice. Proc Soc Exp Biol Med 112:161–165PubMedGoogle Scholar
  42. Sabin AB (1954) Genetic factors affecting susceptibility and resistance to virus disease of the nervous system. Ass Res New Ment Dis Proc 33:57–65Google Scholar
  43. Schultz RM, Chingos MA (1979) Selective neutralization by anti-interferon globulin of macrophage activation by L-cell interferon, Brucella abortus ether extract, Salmonella typhimurium lipopolysaccharide and polyanions. Cell Immunol 48:52–58PubMedCrossRefGoogle Scholar
  44. Shif I, Bang FB (1970) In vitro interaction of mouse hepatitis virus and macrophages from genetically resistant mice. I. Adsorption of virus and growth curve. J Exp Med 131:843–850PubMedCrossRefGoogle Scholar
  45. Stohlman SA, Frelinger JA, Weiner LP (1980) Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM. II. Adherent cell-mediated protection. J Immunol 124: 1733–1739PubMedGoogle Scholar
  46. Taguchi F, Hirano N, Kiuchi Y, Fujiwara K (1976) Difference in response to mouse hepatitis virus among susceptible mouse strains. Japan J Microbiol 20:293–302Google Scholar
  47. Tardieu M, Hery C, Dupuy JM (1980) Neonatal susceptibility to MHV-3 infection in mice. II. Role of natural effector marrow cells in transfer of resistance. J Immunol 124:418–423PubMedGoogle Scholar
  48. Valle MJ, Bobrove AM, Strober S, Merigan TC (1975) Immune specific production of interferon by human T cells in combined macrophage-lymphocyte cultures in response to herpes simplex antigen. J Immunol 114:435–441PubMedGoogle Scholar
  49. Virelizier JL (1972) Etude virologique et immunologique d’une virose persistante chez la souris infectée par le virus de l’hépatite murine (MHV-3). MD dissertation, University of Paris-SudGoogle Scholar
  50. Virelizier JL (1979a) Pathogenesis of mouse hepatitis virus (MHV-3) infection in various inbred strains of mice. In: Bachmann PA (ed) Mechanisms of viral pathogenesis and virulence. WHO, München, p 251Google Scholar
  51. Virelizier JL (1979b) Effects of immunosuppressive agents on leucocyte interferon production in normal or thymus-deprived mice. Transplantation 27:353–355PubMedCrossRefGoogle Scholar
  52. Virelizier JL (1980) Immunological aspects of interferon secretion. In: Collier LH, Oxford J (eds) Developments in antiviral chemotherapy. Academic Press, London New York, p 201Google Scholar
  53. Virelizier JL, Allison AC (1976) Correlation of persistent mouse hepatitis (MHV-3) infection with its effect on mouse macrophage cultures. Arch Virol 50:279–285PubMedCrossRefGoogle Scholar
  54. Virelizier JL, Gresser I (1978) Role of interferon in the pathogenesis of viral diseases of mice as demonstrated by the use of anti-interferon serum. V. Protective role in mouse hepatitis virus type 3 infection of susceptible and resistant strains of mice. J Immunol 120:1616–1619PubMedGoogle Scholar
  55. Virelizier JL, Guy-Grand D (1980) Immune interferon secretion as an expression of immunological memory to transplantation antigens: in vivo generation of long-lived, recirculating memory cells. Eur J Immunol 10:375–379PubMedCrossRefGoogle Scholar
  56. Virelizier JL, Dayan AD, Allison AC (1975) Neuropathological effects of persistent infection of mice by mouse hepatitis virus. Infect 12:1127–1140Google Scholar
  57. Virelizier JL, Virelizier AM, Allison AC (1976) The role of circulating interferon in the modifications of immune responsiveness by mouse hepatitis virus (MHV-3). J Immunol 117:748–753PubMedGoogle Scholar
  58. Weiner LP (1973) Pathogenesis of demyelination induced by a mouse hepatitis virus (JHM virus). Arch Neurol 28:298–303PubMedCrossRefGoogle Scholar
  59. Willenborg DO, Shan KV, Bang FB (1973) Effect of cyclophosphamide on the genetic resistance of C3H mice to mouse hepatitis virus. Proc Soc Exp Biol Med 142:762–766PubMedGoogle Scholar
  60. Zisman B, Hirsch MS, Allison AC (1970) Selective effects of anti-macrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes virus infection of young adult mice. J Immunol 104:1155–1159PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1981

Authors and Affiliations

  • Jean-Louis Virelizier
    • 1
  1. 1.Groupe d’ Immunologic et de Rhumatologie Pédiatriques, INSERM U132Hôpital des Enfants-MaladesParis Cédex 15France

Personalised recommendations